Graves' orbitopathy: a multidisciplinary approach.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... Pub Date : 2021-06-01 Epub Date: 2021-02-26 DOI:10.23736/S1824-4785.21.03350-1

Paolo P Limone, Marco Mellano, Maria G Ruo Redda, Annalisa Macera, Vittorio Ferrero, Stefano Sellari Franceschini, Maurilio Deandrea

{"title":"Graves' orbitopathy: a multidisciplinary approach.","authors":"Paolo P Limone, Marco Mellano, Maria G Ruo Redda, Annalisa Macera, Vittorio Ferrero, Stefano Sellari Franceschini, Maurilio Deandrea","doi":"10.23736/S1824-4785.21.03350-1","DOIUrl":null,"url":null,"abstract":"<p><p>Orbitopathy is the main extra thyroidal manifestation of Graves' disease. It is a very challenging condition, which requires a cooperation between many specialists (endocrinologists, ophthalmologists, radiologists, radiotherapeutic, orbital surgeons) for an optimal clinical management. An accurate diagnostic assessment is required, in order to plan an adequate treatment of Graves' orbitopathy. Medical therapy, radiotherapy or surgery may be necessary to control the disease. In this review, the authors analyze the various therapeutic strategies, as well the more recent therapies based on pharmacologic immunomodulation.</p>","PeriodicalId":23069,"journal":{"name":"The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...","volume":"65 2","pages":"157-171"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S1824-4785.21.03350-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/2/26 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

Abstract

Orbitopathy is the main extra thyroidal manifestation of Graves' disease. It is a very challenging condition, which requires a cooperation between many specialists (endocrinologists, ophthalmologists, radiologists, radiotherapeutic, orbital surgeons) for an optimal clinical management. An accurate diagnostic assessment is required, in order to plan an adequate treatment of Graves' orbitopathy. Medical therapy, radiotherapy or surgery may be necessary to control the disease. In this review, the authors analyze the various therapeutic strategies, as well the more recent therapies based on pharmacologic immunomodulation.

查看原文本刊更多论文

Graves眼病:多学科方法。

眼眶病是Graves病甲状腺外的主要表现。这是一种非常具有挑战性的疾病，需要许多专家(内分泌学家、眼科医生、放射科医生、放射治疗医生、眶外科医生)的合作才能获得最佳的临床治疗。准确的诊断评估是必要的，以便计划适当的治疗Graves眼病。为了控制这种疾病，可能需要药物治疗、放射治疗或手术。在这篇综述中，作者分析了各种治疗策略，以及最近基于药物免疫调节的治疗方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

自引率

0.00%

发文量